Joshua Elkington
UnclaimedCurrent Firm
Axial VC
Investments
10+ companies
Focus
Biotech, AI
About Joshua Elkington
Joshua Elkington runs Axial, an early-stage life sciences investment firm that describes itself as an agency for great inventors. Axial partners with founders and inventors and invests in life sciences companies often when they are no more than an idea, saying it is fanatical about helping the rare inventor who is compelled to build their own enduring business. Elkington writes the firm's Axial publication on Substack, which has hundreds of thousands of subscribers. Axial's partnerships and investments include Lyell Immunopharma, which went public, Charm Therapeutics, BigHat Biosciences, Appia Bio, Delix Therapeutics, Simcha Therapeutics, Parallel Bio, Glyphic Biotechnologies, Arda Therapeutics and Concerto Biosciences, along with exits at Enable Medicine, Revela, Cella Farms and Replay Therapeutics.
Focus Areas
Investment Stage
Notable Investments
Investment Profile
Joshua Elkington is a Founder and General Partner, Axial VC at Axial VC.
Joshua's investment focus spans Biotech, AI, Digital Health, Agriculture, primarily investing at the Pre-Seed, Seed, Series A, Series B+ stages. This specialization allows for deep domain knowledge and strong network effects that benefit portfolio companies.
Notable investments include Lyell Immunopharma, Charm Therapeutics, BigHat Biosciences, Appia Bio, Delix Therapeutics and 5 other companies. These investments span Biotech and AI.
Frequently Asked Questions
Who is Joshua Elkington?
Joshua Elkington is a Founder and General Partner, Axial VC at Axial VC. Their investment focus includes Biotech, AI, Digital Health.
What does Joshua Elkington invest in?
Joshua Elkington focuses on investments in Biotech, AI, Digital Health, Agriculture through Axial VC. These focus areas reflect their domain expertise and the types of startups they actively seek to back.
What are Joshua Elkington's most notable investments?
Joshua Elkington's notable portfolio investments include Lyell Immunopharma, Charm Therapeutics, BigHat Biosciences, Appia Bio, Delix Therapeutics. These companies span multiple sectors and stages, reflecting a track record of identifying high-potential startups.
What firm is Joshua Elkington at?
Joshua Elkington is currently at Axial VC, serving as Founder and General Partner, Axial VC.
Fund Operations Resources
Independent guides to the software and workflows venture investors and their firms use to run funds.
Best Fund Administration Software
Independent breakdown of fund administration platforms by fund size.
LP Reporting Software
Tools for capital account statements and investor updates.
Portfolio Monitoring Tools
How GPs track company performance across the portfolio.
VC CRM Software
Deal-flow and relationship management for investors.
Related tools and reading
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.